SOUTH AFRICA – Biopharmaceutical company Biovac Institute has secured a €15M (US$ 16.08M) grant from the European Investment Bank and the European Union to prepare feasibility studies, finance preparatory works…
Read MoreSA’s Biovac bags US$16M financing from EIB to expand capacity for vaccine manufacturing
